BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,130 filers reported holding BAXTER INTL INC in Q1 2022. The put-call ratio across all filers is 1.41 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $219 | -99.9% | 4,287 | -0.0% | 0.05% | -14.0% |
| Q3 2022 | $245,000 | -20.7% | 4,288 | -10.8% | 0.06% | -18.6% |
| Q2 2022 | $309,000 | -17.2% | 4,805 | 0.0% | 0.07% | -2.8% |
| Q1 2022 | $373,000 | -11.6% | 4,805 | 0.0% | 0.07% | -11.1% |
| Q4 2021 | $422,000 | +8.5% | 4,805 | -0.6% | 0.08% | +11.0% |
| Q3 2021 | $389,000 | -1.0% | 4,836 | 0.0% | 0.07% | -13.1% |
| Q2 2021 | $393,000 | -5.8% | 4,836 | -2.2% | 0.08% | -7.7% |
| Q1 2021 | $417,000 | +6.4% | 4,946 | +1.0% | 0.09% | 0.0% |
| Q4 2020 | $392,000 | +1.3% | 4,895 | 0.0% | 0.09% | -19.5% |
| Q3 2020 | $387,000 | -10.0% | 4,895 | -1.1% | 0.11% | -11.0% |
| Q2 2020 | $430,000 | +19.8% | 4,950 | +11.9% | 0.13% | -9.9% |
| Q1 2020 | $359,000 | -23.0% | 4,424 | -13.6% | 0.14% | -4.1% |
| Q4 2019 | $466,000 | +4.7% | 5,119 | 0.0% | 0.15% | -64.3% |
| Q3 2019 | $445,000 | +5.5% | 5,119 | +2.0% | 0.41% | +184.1% |
| Q2 2019 | $422,000 | +16.9% | 5,020 | -12.8% | 0.14% | -4.6% |
| Q3 2017 | $361,000 | -1.1% | 5,759 | -4.4% | 0.15% | -15.6% |
| Q2 2017 | $365,000 | -5.7% | 6,024 | -13.2% | 0.18% | +6.5% |
| Q1 2017 | $387,000 | +21.3% | 6,939 | -3.5% | 0.17% | +5.0% |
| Q4 2016 | $319,000 | -11.6% | 7,189 | -5.2% | 0.16% | -10.1% |
| Q3 2016 | $361,000 | 0.0% | 7,587 | -1.8% | 0.18% | -10.9% |
| Q2 2016 | $361,000 | +13.9% | 7,728 | +6.1% | 0.20% | -9.9% |
| Q1 2016 | $317,000 | +4.6% | 7,285 | -10.1% | 0.22% | +6.2% |
| Q4 2015 | $303,000 | +13.5% | 8,103 | -0.6% | 0.21% | +18.0% |
| Q3 2015 | $267,000 | -52.2% | 8,151 | +2.1% | 0.18% | -50.0% |
| Q2 2015 | $558,000 | +1.8% | 7,985 | 0.0% | 0.36% | -1.1% |
| Q1 2015 | $548,000 | -6.3% | 7,985 | 0.0% | 0.36% | -9.8% |
| Q4 2014 | $585,000 | +5.2% | 7,985 | 0.0% | 0.40% | +8.7% |
| Q3 2014 | $556,000 | -7.5% | 7,985 | -3.9% | 0.37% | +1.1% |
| Q2 2014 | $601,000 | -1.3% | 8,310 | +0.1% | 0.36% | -14.6% |
| Q1 2014 | $609,000 | +8.0% | 8,305 | 0.0% | 0.42% | +11.8% |
| Q4 2013 | $564,000 | +7.8% | 8,305 | +1.5% | 0.38% | -15.9% |
| Q3 2013 | $523,000 | – | 8,180 | – | 0.45% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |